This paper analyzes the off-label use of drugs in our hospital in November 2013. The results show that off-label use of drugs exists objectively in clinical practice, most of which have pharmacological and literature basis, and there are also some potential drug risks; it is suggested to fully evaluate its safety and rationality, and improve the level of safe and rational drug use.
This document is a research article published in the journal China Pharmacy, titled 'Analysis of Off-label Use in Our Hospital in Nov. 2013'. It presents a retrospective analysis of 11,000 prescriptions containing Chinese patent medicine, chemical drugs, or biological products prescribed in November 2013 at Liwan Hospital of Guangzhou Medical College.
The study identified 2,784 prescriptions (25.30%) and 4,307 medication orders (14.37%) as off-label use. The analysis categorized these instances by type, such as changing the route of administration (35.52%), insufficient dosage (19.53%), and inappropriate indications (12.17%). The authors concluded that while off-label use exists objectively and often has pharmacological basis, it carries risks and requires full evaluation of safety and rationality. This manual is written in Chinese.